Aurobindo Pharma reports 12% fall in Q4 consolidated net profit

29 May 2023 Evaluate

Aurobindo Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported 19.62% fall in its net profit at Rs 644.80 crore for the quarter under review as compared to Rs 802.16 crore for the same quarter in the previous year. However, total income of the company increased by 16.21% at Rs 3,835.61 crore for Q4FY23 as compared to Rs 3,300.54 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 12.19% fall in its net profit at Rs 505.91 crore for fourth quarter ended March 31, 2023 as compared to Rs 576.14 crore for the same quarter in the previous year. However, total income of the company increased by 12.80% at Rs 6,607.87 crore for Q4FY23 as compared to Rs 5,858.25 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported 15.42% fall in its net profit at Rs 1,230.41 crore as compared to Rs 1,454.71 crore for the previous year. However, total income of the company increased by 10.60% at Rs 13,226.04 crore for year under review as compared to Rs 11,958.13 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported 27.18% fall in its net profit at Rs 1,927.65 crore as compared to Rs 2,647.11 crore for the previous year. However, total income of the company increased by 5.76% at Rs 25,145.97 crore for year under review as compared to Rs 23,775.84 crore for year ended March 31, 2022.

Aurobindo Pharma Share Price

1144.55 -22.65 (-1.94%)
20-Jan-2026 15:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1381.00
Zydus Lifesciences 872.95
Lupin 2160.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×